Bladder Disorders Market analysis report has several benefits which can be projected to wide-ranging aspects of Healthcare industry. It also encompasses analysis, estimation, and discussion of important industry trends, market size, and market share. According to this market document, new highs will take place in the Bladder Disorders Market . This is the most promising market analysis report which has been structured in the way anticipated. The report studies rising opportunities in the market and associated influencing factors which are valuable for the businesses. So, to gain competitive advantage and to thrive in the market, go for Bladder Disorders Market research report.

Global bladder disorders market is expected to grow in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.4% in the forecast period of 2022 to 2029 and is expected to reach USD 22,342.48 million by 2029.

Download PDF Sample of Bladder Disorders Market @

Bladder related disorders include cystitis – inflammation of the bladder, often from an infection, Urinary incontinence – loss of bladder control, Overactive bladder – a condition in which the bladder squeezes urine out at the wrong time, Interstitial cystitis – a chronic problem that causes bladder pain and frequent, urgent urination and bladder cancer.

The Bladder Disorders Market is dominated by Firms Such as:

  • Medtronic
  • Laborie
  • Boston Scientific Corporation
  • Pfizer Inc.
  • Astellas Pharma Inc.
  • KYORIN Pharmaceutical Co., Ltd. (A subsidiary of KYORIN Holdings, Inc.)
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Axonics, Inc.
  • Merck & Co., Inc.
  • Viatris Inc.
  • Blue Wind Medical
  • Valencia Technologies
  • Gaylord Chemical Company
  • L.L.C.
  • Coloplast Corp
  • AbbVie Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Zydus Group
  • Swati Spentose
  • Urovant Sciences

Market Development:

  • In August 2021, Vensica Therapeutics Ltd and wMerz Therapeutics announced that they have entered into a collaboration agreement and strategic license for the delivery of botulinum neurotoxin A (Xeomin) to the bladder wall by using Vensica’s innovative ultrasound-assisted delivery catheter
  • In March 2022, Urovant Sciences declared positive topline results from its Phase 2a, double-blind, placebo-controlled exploratory study of URO-902. It is an investigational, novel, locally injected gene therapy product that is used in those patients with overactive bladder (OAB), who did not respond well to oral therapies. These results suggest that URO-902 could deliver new treatment for patients with overactive bladder who have been inadequately respond by oral pharmacologic therapy
  • In June 2021, Taiho Pharmaceutical has developed, TAC-302 which is a medicine in Phase II development. This medication is orally works and accessible by supporting neurite outgrowth activity in cultured peripheral neurons to cure overactive bladder. The introduction of this new innovative treatment choices will increase patient uptake, which will fuel the expansion of the market
  • In December 2019, Johnson & Johnson announced the acquisition with TARIS Biomedical LLC Company, a private limited biotechnology corporation that produces high-quality new and innovative drug delivery procedures for the treatment of bladder disorders, including cancer. The TAR-200 is a leading clinical-stage product of the business which used in the patented TARIS System. This silicone-based drug delivery system allows constant drug release into the bladder. The financial details of transactions are not being publicly disclosed.

Get Full PDF Research Report @

Bladder Disorders Market Scope


  • Cystitis
  • Urinary Incontinence
  • Overactive Bladder
  • Interstitial Cystitis
  • Bladder Cancer

Treatment type

  • Surgery
  • Medications
  • Others

End User

  • Hospital
  • Clinics
  • Ambulatory Surgery centers
  • Others

Distribution Channel

  • Direct
  • Retail

Market intelligence platform will help you understand:

  • Identify emerging market trends & dynamics
  • Market intelligence with quality and accuracy
  • Benchmark against competitors & industry
  • Explore competitive strategy & market share
  • Discover regional market opportunities
  • Deliverable formats include PDF, PPT, Excel & Online Dashboard

View Detailed Research on Bladder Disorders Market @

Bladder Disorders Market Regional Analysis/Insights 

The bladder disorders market report is analyzed, and market size insights and trends are provided by country, type, treatment type, end user, and distribution channel, as referenced above

Countries covered in this market are U.S., CanadaMexicoGermany, U.K., FranceItalySpainTurkeyRussiaNetherlandsSwitzerlandBelgium and Rest of EuropeChinaJapanIndiaSouth KoreaAustraliaSingaporeThailandMalaysiaIndonesiaPhilippinesVietnam, Rest of Asia-PacificBrazilArgentinaPeru, Rest of South AmericaSouth AfricaSaudi Arabia, U.A.E, EgyptIsrael, Rest of the Middle East and Africa.

North America dominates the global bladder disorders market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to the high prevalence of overactive bladder disorder in the region, and growing R&D investments and the launch of novel therapies are boosting the market

A comprehensive analysis will be provided covering the following points in the report:

  • Executive Market Summary
  • Scope of the Bladder Disorders Report
  • Key Finding and Recommendations
  • Growth and Investment Opportunities
  • Bladder Disorders Market Value Chain/Supply Chain Analysis
  • Bladder Disorders Market Attractive Investment Proposition
  • Competitive landscape and SWOT Analysis
  • Bladder Disorders Market Segmentation Outlook
  • Regional Outlook
  • Company Profiles of Key Players

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global Bladder Disorders market over the period. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Download Full Table of Contents @

Explore DBMR Comprehensive Coverage on Healthcare Domain:

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475